The aim of this retrospective study is to compare the efficacy of the American Society of Anesthesiologists (ASA) physical status classification and the Clinical Frailty Scale (CFS) in predicting postoperative intensive care unit (ICU) requirements in geriatric patients undergoing hip fracture surgery. The investigators will analyze medical records of patients aged 65 and older. The study will evaluate whether the CFS provides better predictive value for ICU admission compared to the traditional ASA score in this specific surgical population.
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:Age: Patients aged 65 years and older.
Diagnosis: Patients diagnosed with acute traumatic hip fracture, including femoral neck, intertrochanteric, or subtrochanteric fractures.
Surgical Intervention: Patients who have undergone or are scheduled for surgical treatment (e.g., arthroplasty, internal fixation/osteosynthesis) for hip fracture.
Data Integrity: Availability of complete electronic health records, including preoperative anesthesia evaluation forms and ASA physical status scores.
Functional Assessment: Presence of sufficient clinical and nursing documentation to retrospectively determine the Clinical Frailty Scale (CFS) score based on preoperative functional status.
\-
Exclusion Criteria:Pathological and Periprosthetic Fractures: Fractures resulting from bone metastases or those occurring around an existing prosthesis.
Multiple Trauma: Patients with concomitant major organ injuries or additional limb fractures that could impact clinical outcomes.
Conservative Management: Patients who did not undergo surgical intervention and were managed non-surgically.
Incomplete Data: Cases with missing ASA scores, laboratory results, or postoperative clinical follow-up data in the hospital records.
Insufficient Functional Documentation: Patients whose clinical or nursing notes are inadequate for retrospective determination of the Clinical Frailty Scale (CFS) score.
Patient Transfer: Patients transferred to another healthcare facility preoperatively or i…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Postoperative Intensive Care Unit (ICU) Admission Requirement
Timeframe: Within 24 hours postoperatively
Trial details
NCT IDNCT07522541
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital